American Public Health Association (APHA)

APHA issues rallying cry over mental health in midst of COVID-19 pandemic

Newswise — The American Public Health Association is sounding the alarm about the massive wave of mental health problems linked to the COVID-19 pandemic. 

More than 60 million people in the United States live with mental or substance use disorders, according to the Substance Abuse and Mental Health Administration. Now, nearly half of Americans say the pandemic is harming their mental health. Calls to crisis hotlines are increasing by 1,000%. According to a new report released by Well Being Trust and the Robert Graham Center for Policy Studies in Family Medicine and Primary Care, more Americans are feeling scared, distressed, anxious, depressed and hopeless, leading to a possible increase of 75,000 deaths. APHA has long supported parity for physical and mental health and believes we need to pay attention now more than ever to reduce these deaths of despair.

“Right now, everyone knows someone who is struggling with mental health, if they aren’t struggling themselves,” said Lisa M. Carlson, president of APHA. 

She said the public mental health infrastructure, which is disjointed and lacks cohesive planning, needs an overhaul. Mental health programs are underfunded, leaving less than half the people who need treatment able to receive it.

“Every time we talk about public health, we should be talking about mental health,” Carlson said. “They are interconnected.” 

APHA, a Washington, D.C.- based organization with more than 25,000 health professional members and a nearly 150-year history, supports short-term steps necessary to address the current challenges related to COVID-19. At the same time, additional action is needed to ensure mental health and substance use health services are readily available to all Americans — regardless of their socioeconomic status, location or age — during and after this crisis. 

The current shortage of mental health professionals along with the lack of enough clinics, training and education programs leaves many communities unable to access the care they need. Minority and disadvantaged communities especially lack access to mental health services and practitioners.   

“This is indicative of the larger problem in public health. We’re not truly embracing public health as we ought to,” Carlson added. “We panic and make available some nominal support for public health, and public health does its job, so we defund public health, and we are back in the cycle again.” 

APHA supports a variety of approaches to sustain well-being (mindfulness, yoga, deep-relaxation techniques) and in managing disaster-related distress, such as accessing Psychological First Aid or the national Disaster Distress Helpline. The organization reminds people it is also important to stay in touch with any support networks they have as well as use online tools. Carlson recently spoke out about the ways we can look out for our mental wellness, including tapping into the calming power of nature. One key is to maintain social connectedness while practicing physical distancing.

“These are challenging times for all of us,” Carlson said. “Help us bring attention to the urgent need to prioritize mental health supports for everyone and to address the perfect storm of the COVID-19 toll on physical and mental health alike.”

                                                                                              ###

The American Public Health Association champions the health of all people and all communities. We are the only organization that combines a nearly 150-year perspective, a broad-based member community and the ability to influence federal policy to improve the public’s health. Learn more at www.apha.org.

 




Filters close

Showing results

110 of 3321
Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 5:50 PM EDT
AERA and OECD to Co-Host Webinar on Education Research Worldwide in a Covid and Post-Covid World
American Educational Research Association (AERA)

The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.

Newswise: 243232_web.jpg
Released: 17-Sep-2020 4:20 PM EDT
Study shows first proof that a safer UV light effectively kills virus causing COVID-19
Hiroshima University

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Newswise:Video Embedded american-academy-of-dermatology-honors-detroit-physician-iltefat-h-hamzavi-with-national-patient-care-hero-award
VIDEO
Released: 17-Sep-2020 4:00 PM EDT
American Academy of Dermatology honors Detroit physician Iltefat H. Hamzavi with national “Patient Care Hero” award
American Academy of Dermatology

The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Sep-2020 11:00 AM EDT Released to reporters: 17-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Sep-2020 3:05 PM EDT
New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test
Mount Sinai Health System

The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood


Showing results

110 of 3321

close
1.41999